[go: up one dir, main page]

FR3041535B1 - Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose. - Google Patents

Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose. Download PDF

Info

Publication number
FR3041535B1
FR3041535B1 FR1559201A FR1559201A FR3041535B1 FR 3041535 B1 FR3041535 B1 FR 3041535B1 FR 1559201 A FR1559201 A FR 1559201A FR 1559201 A FR1559201 A FR 1559201A FR 3041535 B1 FR3041535 B1 FR 3041535B1
Authority
FR
France
Prior art keywords
trifarotene
ichtyose
treatment
foam containing
chemical foam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1559201A
Other languages
English (en)
Other versions
FR3041535A1 (fr
Inventor
Jean-Christophe Buge
Karine NADAU-FOURCADE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1559201A priority Critical patent/FR3041535B1/fr
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to EP16775633.7A priority patent/EP3355859A1/fr
Priority to JP2018535246A priority patent/JP2018529773A/ja
Priority to MX2018003640A priority patent/MX382168B/es
Priority to US15/763,753 priority patent/US11020348B2/en
Priority to CN201680069627.XA priority patent/CN108289838A/zh
Priority to KR1020187012168A priority patent/KR20180057713A/ko
Priority to PCT/EP2016/073014 priority patent/WO2017055297A1/fr
Priority to AU2016330790A priority patent/AU2016330790B2/en
Publication of FR3041535A1 publication Critical patent/FR3041535A1/fr
Application granted granted Critical
Publication of FR3041535B1 publication Critical patent/FR3041535B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne une composition contenant du trifarotène destinée à une application topique non rincée et se présentant sous la forme d'une mousse non rincée destinée à être appliquée sur la peau, comprenant: - au moins une composition intermédiaire, - au moins un agent générateur de gaz, - au moins un agent activateur de l'agent générateur de gaz, et - du trifarotène ou l'un de ses sels pharmaceutiquement acceptables. La présente invention concerne également un kit ou un contenant unique à plusieurs compartiments contenant une telle composition.
FR1559201A 2015-09-29 2015-09-29 Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose. Expired - Fee Related FR3041535B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR1559201A FR3041535B1 (fr) 2015-09-29 2015-09-29 Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
JP2018535246A JP2018529773A (ja) 2015-09-29 2016-09-27 トリファロテンを含有する濯がないケミカルフォーム、及び魚鱗癬の処置におけるその使用
MX2018003640A MX382168B (es) 2015-09-29 2016-09-27 Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis.
US15/763,753 US11020348B2 (en) 2015-09-29 2016-09-27 No-rinse chemical foam containing trifarotene, and use thereof in the treatment of ichthyosis
EP16775633.7A EP3355859A1 (fr) 2015-09-29 2016-09-27 Mousse chimique non rincée contenant du trifarotène, et son utilisation dans le traitement de l'ichtyose
CN201680069627.XA CN108289838A (zh) 2015-09-29 2016-09-27 含有曲法罗汀的免冲洗化学泡沫，以及它们在治疗鱼鳞癣中的用途
KR1020187012168A KR20180057713A (ko) 2015-09-29 2016-09-27 트리파로텐을 함유하는 비-헹굼 화학 발포체, 및 어린선의 치료에 있어서의 그의 용도
PCT/EP2016/073014 WO2017055297A1 (fr) 2015-09-29 2016-09-27 Mousse chimique non rincée contenant du trifarotène, et son utilisation dans le traitement de l'ichtyose
AU2016330790A AU2016330790B2 (en) 2015-09-29 2016-09-27 No-rinse chemical foam containing trifarotene, and use thereof in the treatment of ichthyosis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1559201A FR3041535B1 (fr) 2015-09-29 2015-09-29 Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
FR1559201 2015-09-29

Publications (2)

Publication Number Publication Date
FR3041535A1 FR3041535A1 (fr) 2017-03-31
FR3041535B1 true FR3041535B1 (fr) 2019-01-25

Family

ID=54848734

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1559201A Expired - Fee Related FR3041535B1 (fr) 2015-09-29 2015-09-29 Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.

Country Status (9)

Country Link
US (1) US11020348B2 (fr)
EP (1) EP3355859A1 (fr)
JP (1) JP2018529773A (fr)
KR (1) KR20180057713A (fr)
CN (1) CN108289838A (fr)
AU (1) AU2016330790B2 (fr)
FR (1) FR3041535B1 (fr)
MX (1) MX382168B (fr)
WO (1) WO2017055297A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6997222B2 (ja) 2017-06-23 2022-01-17 ザ プロクター アンド ギャンブル カンパニー 皮膚の外観を改善するための組成物及び方法
US11622963B2 (en) 2018-07-03 2023-04-11 The Procter & Gamble Company Method of treating a skin condition
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
KR100631000B1 (ko) 1997-11-07 2006-10-04 가부시끼가이샤 메디온 리서치 라보라토리즈 이산화탄소 함유 점성 제약 조성물
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US5952372A (en) 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6177092B1 (en) 1998-11-10 2001-01-23 Color Access, Inc. Self-foaming cleansing systems
US6133310A (en) 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6399652B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
FR2830415B1 (fr) 2001-10-09 2004-07-09 Rhodia Chimie Sa Utilisation d'une composition a base de gomme xanthane en tant que stabilisant de mousses molles, et les mousses a base de cette composition
JP2006505583A (ja) * 2002-10-25 2006-02-16 フォーミックス エルティーディー． 化粧剤および医薬用フォーム
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
US20050123487A1 (en) 2003-12-08 2005-06-09 Spadini Alessandro L. Stable nonaqueous liquid reactive skin care and cleansing packaged product
US20060057075A1 (en) 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US8916050B2 (en) 2004-09-27 2014-12-23 Special Water Patents B.V. Methods and compositions for treatment of water
ES2582654T3 (es) 2006-03-31 2016-09-14 Stiefel Research Australia Pty Ltd Gel en suspensión espumable
WO2009069006A2 (fr) 2007-11-30 2009-06-04 Foamix Ltd. Peroxyde de benzoyle contenant de la mousse
FR2924944A1 (fr) 2007-12-18 2009-06-19 Galderma Sa Composition a base d'une avermectine et du soufre ou d'un derive du soufre, notamment pour le traitement de la rosacee
US10589134B2 (en) 2008-01-30 2020-03-17 Kimberly-Clark Worldwide, Inc. Hand health and hygiene system for hand health and infection control
DE102008029357A1 (de) 2008-06-20 2009-12-24 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Schäumende kosmetische Zubereitung
WO2010086726A1 (fr) 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions pour le traitement des ongles et de la peau
FR2943914A1 (fr) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
JP2012526840A (ja) 2009-05-13 2012-11-01 プロテイン デリヴァリー ソリューションズ エルエルシー 膜貫通送達のための製剤系
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
US20110236503A1 (en) 2010-03-23 2011-09-29 Cosmalabs International, Llc Topical Skincare Composition
RU2587041C2 (ru) 2010-06-30 2016-06-10 Галдерма Ресерч Энд Девелопмент Способ предотвращения или лечения опухоли кожи
EP2620138B1 (fr) 2010-09-24 2016-12-07 Daido Chemical Corporation Préparation cutanée externe de type mousse
FR2969491B1 (fr) 2010-12-23 2013-07-12 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
FR2969492B1 (fr) 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
FR2969493B1 (fr) 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant du bpo
US9301935B2 (en) 2013-06-10 2016-04-05 Naeem Uddin Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
CA2915206A1 (fr) 2013-06-17 2014-12-24 Contract Pharmaceuticals Limited Mousses non aerosol pour l'administration topique
EP3076944A1 (fr) * 2013-12-04 2016-10-12 Galderma Research & Development Microcapsules lipidiques comprenant de preference un actif lipophile et composition les contenant, leur procede de preparation et leur utilisation en dermatologie et en cosmetique
US10449175B2 (en) 2014-03-28 2019-10-22 Galderma Research & Development Rinse-off chemical mousse containing benzoyl peroxide
KR20160137592A (ko) 2014-03-28 2016-11-30 갈데르마 리써어치 앤드 디벨로프먼트 벤조일 퍼옥시드 함유 비-헹굼 화학적 무스
CN104382863B (zh) 2014-11-29 2017-07-07 河南后羿实业集团有限公司 一种禽用伊维菌素泡腾颗粒
ITUB20161027A1 (it) * 2016-02-24 2017-08-24 Altergon Sa Preparazioni farmaceutiche oromucosali ad elevata biodisponibilita’ a base di ciclodestrina e sucralosio
CA2978573A1 (fr) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions et methodes de traitement de la rosacee et de l'acnee
CN107312205B (zh) * 2017-06-15 2020-02-11 淮阴工学院 凹土负载壳聚糖交联环糊精复合物的制备及其应用

Also Published As

Publication number Publication date
AU2016330790A1 (en) 2018-05-10
US20180280298A1 (en) 2018-10-04
MX382168B (es) 2025-03-13
AU2016330790B2 (en) 2022-05-12
JP2018529773A (ja) 2018-10-11
MX2018003640A (es) 2018-04-30
KR20180057713A (ko) 2018-05-30
WO2017055297A1 (fr) 2017-04-06
FR3041535A1 (fr) 2017-03-31
US11020348B2 (en) 2021-06-01
EP3355859A1 (fr) 2018-08-08
CN108289838A (zh) 2018-07-17

Similar Documents

Publication Publication Date Title
FR3041535B1 (fr) Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
EP1606264A4 (fr) Antagonistes des recepteurs du cgrp d'anilide spirohydantoine monocyclique
MX361450B (es) Espuma química sin enjuague que comprende peróxido de benzoilo.
MY172157A (en) Thioninium compounds and their use
MX2009003157A (es) Pirazoliltienopiridinas terapeuticas.
NO20072322L (no) Laktamforbindelser og anvendelse derav som farmasoytiske midler
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
MX2016012363A (es) Espuma quimica que se remueve con enjuague que contiene peroxido de benzoilo.
MX390495B (es) Uso de masitinib para el tratamiento de una subpoblación de pacientes con esclerosis lateral amiotrófica.
GB0223040D0 (en) Therapeutic compounds
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
BRPI0514736A (pt) inibidores do receptor sigma
PL417066A1 (pl) Inhibitory arginazy oraz ich zastosowania terapeutyczne
EP1951251A4 (fr) Antagonistes du recepteur cgrp de spirohydatoin aryle
CY1113439T1 (el) Ενωση αζολιου
MX378653B (es) Composicion limpiadora auto-espumante para enjuagar que contiene ivermectina.
EP3674307A4 (fr) Macrocycle contenant de l'aminopyrazole et de la pyrimidine, composition pharmaceutique et utilisation de celui-ci
PH12019501514A1 (en) Integrin antagonists
FR3041538B1 (fr) Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
EA202092820A1 (ru) Композиция для расслабления мышц
CL2007003190A1 (es) Compuestos derivados de arilsulfonil-pirrolidinas; procedimiento de obtencion; composicion farmaceutica; y uso en la prevencion o tratamiento de enfermedades tales como psicosis, depresion, alzheimer, entre otras.
DK1962815T3 (da) Anvendelse af filmdannende hårplejepolymerer fra gruppen polyurethaner og farmaceutiske tilberedninger og plastre indeholdende nævnte polymerer
TW200736227A (en) New compounds III
SE0402284D0 (sv) New heterocyclic amides

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20170331

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

ST Notification of lapse

Effective date: 20210506